Work

Abstract 4437: Pimitespib (TAS-116), an HSP90 inhibitor, overcomes resistance to androgen receptor pathway inhibitors in prostate cancer by simultaneously targeting several key resistance mechanisms

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4437

Authors: Hiromi Muraoka, Kazuhisa Minamiguchi, Akihiro Hashimoto, Hiroshi Sootome, Shuichi Ohkubo

Institution: Taiho Pharmaceutical (Japan)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630338

Cites:

Cited by: 1

Related to: 10